Hyaluronidase pharmacological properties and clinical application in ophthalmology
Corneal diseases are the fourth leading cause of blindness in the world, accounting for approximately 5 % of cases. Existing methods of treatment in more than 30 % of cases do not have a full therapeutic effect and when the process is stopped, they end with a persistent violation of corneal transpar...
Main Authors: | V. E. Zabanova, A. Zh. Fursova, P. G. Madonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2020-08-01
|
Series: | Сибирский научный медицинский журнал |
Subjects: | |
Online Access: | https://sibmed.elpub.ru/jour/article/view/447 |
Similar Items
-
Hyaluronidase: An overview of its properties, applications, and side effects
by: Hyunwook Jung
Published: (2020-07-01) -
Hyaluronidases in Human Diseases
by: Aditya Kaul, et al.
Published: (2021-03-01) -
Effect of immobilized hyaluronidase and subtilisin enzymes on the ultrastructure of human conjunctival epithelial cells
by: V. E. Zabanova, et al.
Published: (2023-02-01) -
Carbon Dot/Naphthalimide Based Ratiometric Fluorescence Biosensor for Hyaluronidase Detection
by: Pushap Raj, et al.
Published: (2021-03-01) -
Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema
by: Sébastien Menzinger, et al.
Published: (2016-07-01)